University of California San Francisco | About UCSF | UCSF Medical Center
Search Site | Find a Doctor

Michael R. Harrison, M.D.

Fetal and pediatric surgeon

Dr. Michael Harrison is director emeritus and co-founder of the Fetal Treatment Center at UCSF Benioff Children's Hospital. He is an internationally known expert in fetal surgery, an area he helped pioneer with his colleagues at UCSF. For more than 25 years, he has studied how life-threatening fetal abnormalities alter normal physical processes. He developed techniques for both open surgery and minimally invasive surgery to repair many birth defects. Harrison's team also developed in utero stem cell transplantation to treat immune system deficiencies, enzyme deficiencies and abnormal hemoglobin in the blood.

Harrison graduated cum laude from Yale University and magna cum laude from Harvard Medical School. He completed surgical training at Massachusetts General Hospital in Boston and a pediatric surgery fellowship at Children's Hospital of Los Angeles. He is a professor emeritus of surgery, pediatrics, obstetrics, gynecology and reproductive sciences.

Conditions & Treatments

Clinics

Fetal Treatment Center
400 Parnassus Ave., A123
San Francisco, CA 94143
Phone: (415) 476-0445

Pediatric Prepare Program
400 Parnassus Ave., Third Floor, Room A-334
San Francisco, CA 94143-0210
Phone: (415) 353-1150

More about Michael R. Harrison

Education

Harvard University School of Medicine 1969

Residencies

Massachusetts General Hospital, General Surgery 1975

Fellowships

Los Angeles Children's Hospital, Pediatric Surgery 1978

Selected Research and Publications

  1. Harrison MR, Gonzales KD, Bratton BJ, Christensen D, Curran PF, Fechter R, Hirose S. Magnetic mini-mover procedure for pectus excavatum III: safety and efficacy in a Food and Drug Administration-sponsored clinical trial. J Pediatr Surg. 2012 Jan; 47(1):154-9.
  2. Rosenbluth KH, Kwiat DA, Harrison MR, Kezirian EJ. Hyoid bone advancement for improving airway patency: cadaver study of a magnet-based system. Otolaryngol Head Neck Surg. 2012 Mar; 146(3):491-6.
  3. Harrison MR. Pharmacotherapy options in advanced renal cell carcinoma: what role for pazopanib? Clin Med Insights Oncol. 2011; 5:349-64.
  4. Liu G, Jeraj R, Vanderhoek M, Perlman S, Kolesar J, Harrison M, Simoncic U, Eickhoff J, Carmichael L, Chao B, Marnocha R, Ivy P, Wilding G. Pharmacodynamic Study Using FLT PET/CT in Patients with Renal Cell Cancer and Other Solid Malignancies Treated with Sunitinib Malate. Clin Cancer Res. 2011 Dec 15; 17(24):7634-44.
  5. Harrison MR, George DJ. Better late than early: FDG-PET imaging in metastatic renal cell carcinoma. Clin Cancer Res. 2011 Sep 15; 17(18):5841-3.
  6. Diana M, Wall J, Perretta S, Dallemagne B, Gonzales KD, Harrison MR, Agnus V, Soler L, Nicolau S, Marescaux J. Totally endoscopic magnetic enteral bypass by external guided rendez-vous technique. Surg Innov. 2011 Dec; 18(4):317-20.
  7. Perretta S, Wall JK, Dallemagne B, Harrison M, Becmeur F, Marescaux J. Video: two novel endoscopic esophageal lengthening and reconstruction techniques. Surg Endosc. 2011 Oct; 25(10):3440.
  8. Harrison MR. Tracheal occlusion works. Fetal Diagn Ther. 2011; 29(1):78-9.
  9. Harrison MR, Georgiou AS, Spaink HP, Cunliffe VT. The epigenetic regulator Histone Deacetylase 1 promotes transcription of a core neurogenic programme in zebrafish embryos. BMC Genomics. 2011; 12:24.
  10. Pichakron KO, Jelin EB, Hirose S, Curran PF, Jamshidi R, Stephenson JT, Fechter R, Strange M, Harrison MR. Magnamosis II: Magnetic compression anastomosis for minimally invasive gastrojejunostomy and jejunojejunostomy. J Am Coll Surg. 2011 Jan; 212(1):42-9.
  11. Lightman EG, Harrison MR, Cunliffe VT. Opposing actions of histone deacetylase 1 and Notch signalling restrict expression of erm and fgf20a to hindbrain rhombomere centres during zebrafish neurogenesis. Int J Dev Biol. 2011; 55(6):597-602.
  12. Lang JM, Harrison MR. Pazopanib for the treatment of patients with advanced renal cell carcinoma. Clin Med Insights Oncol. 2010; 4:95-105.
  13. Griva K, Stygall J, Hankins M, Davenport A, Harrison M, Newman SP. Cognitive impairment and 7-year mortality in dialysis patients. Am J Kidney Dis. 2010 Oct; 56(4):693-703.
  14. Deprest JA, Flake AW, Gratacos E, Ville Y, Hecher K, Nicolaides K, Johnson MP, Luks FI, Adzick NS, Harrison MR. The making of fetal surgery. Prenat Diagn. 2010 Jul; 30(7):653-67.
  15. Harrison MR, Hahn NM, Pili R, Oh WK, Hammers H, Sweeney C, Kim K, Perlman S, Arnott J, Sidor C, Wilding G, Liu G. A phase II study of 2-methoxyestradiol (2ME2) NanoCrystal® dispersion (NCD) in patients with taxane-refractory, metastatic castrate-resistant prostate cancer (CRPC). Invest New Drugs. 2011 Dec; 29(6):1465-74.
  16. Jiang H, Zhang JM, Liou SS, Fechter R, Hirose S, Harrison M, Roy S. A high-power versatile wireless power transfer for biomedical implants. Conf Proc IEEE Eng Med Biol Soc. 2010; 2010:6437-40.
  17. Jancelewicz T, Vu LT, Keller RL, Bratton B, Lee H, Farmer D, Harrison M, Miniati D, Mackenzie T, Hirose S, Nobuhara K. Long-term surgical outcomes in congenital diaphragmatic hernia: observations from a single institution. J Pediatr Surg. 2010 Jan; 45(1):155-60; discussion 160.
  18. Harrison MR, Curran PF, Jamshidi R, Christensen D, Bratton BJ, Fechter R, Hirose S. Magnetic mini-mover procedure for pectus excavatum II: initial findings of a Food and Drug Administration-sponsored trial. J Pediatr Surg. 2010 Jan; 45(1):185-91; discussion 191-2.
  19. Harrison MR. What if?... Why not? J Pediatr Surg. 2010 Jan; 45(1):1-10.
  20. Sy ED, Filly RA, Cheong ML, Clifton MS, Cortes RA, Ohashi S, Takifuji K, Ventura DE, Grethel EJ, Wagner AJ, Gress EA, Ball RH, Lee H, Harrison MR. Prognostic role of tumor-head volume ratio in fetal sacrococcygeal teratoma. Fetal Diagn Ther. 2009; 26(2):75-80.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions by logging on to UCSF Profiles.